COMBINED THERAPY OF ALPHA-1-ANTITRYPSIN AND TEMPORAL T-CELL DEPLETION FOR PREVENTING GRAFT REJECTION

• 收藏
• 分享

专利权人:

发明人:

Eli Lewis

申请号：

US14380118

公开号：

US20150010581A1

申请日:

2013.02.27

申请国别(地区):

US

年份:

2015

代理人:

摘要：

The present invention provides compositions and methods for the prevention and treatment of aggressive immune processes to life-saving grafts, such as xenograft rejection, and for attenuating host responses in transplantation of tissues, cells and organs. More specifically, the compositions and methods of the present invention relate to combined therapies comprising treatment of alpha-1-antitrypsin (AAT) and temporary T-cell depletion including but not limited to anti-CD4 and anti-CD8 antibodies.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/